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The spatial epidemiology and clinical features of
reported cases of La Crosse Virus infection in
West Virginia from 2003 to 2007
Andrew D Haddow1,2*, Danae Bixler3, Agricola Odoi4

Abstract
Background: La Crosse virus (LACV) is a major cause of pediatric encephalitis in the United States. Since the mid1980s, the number of reported cases of LACV infection in West Virginia has continued to rise and the state
currently reports the most cases in the United States. The purpose of this study was to investigate and describe
the spatial epidemiology and clinical presentation of LACV infection cases reported in West Virginia, as well as to
provide a description of the environmental conditions present at the residences of the LACV infection cases.
Methods: Descriptive and spatial analyses were performed on LACV infection cases reported to the West Virginia
Department of Health from 2003 to 2007. Clinical and environmental variables were available for 96 cases and
residence data were available for 68 of these cases. Spatial analyses using the global Moran’s I and Kulldorff’s
spatial scan statistic were performed using the population 15 years and younger at both the county and census
tract levels to identify those geographic areas at the highest risk of infection.
Results: Two statistically significant (p < 0.05) high-risk clusters, involving six counties, were detected at the county
level. At the census tract level, one statistically significant high-risk cluster involving 41 census tracts spanning over
six counties was identified. The county level cumulative incidence for those counties in the primary high-risk
cluster ranged from 100.0 to 189.0 cases per 100,000 persons (median 189.0) and the census tract level cumulative
incidence for those counties in the high-risk cluster ranged from 61.7 to 505.9 cases per 100,000 persons (median
99.0). The counties and census tracts within high-risk clusters had a relative risk four to nine times higher when
compared to those areas not contained within high-risk clusters. The majority of LACV infection cases were
reported during the summer months in children 15 years and younger. Fever, vomiting, photophobia, and nausea
were the most commonly reported signs and symptoms. A case fatality rate (CFR) of 3.1% was observed. Wooded
areas and containers were present at the majority of case residences.
Conclusions: The cumulative incidences of LACV infection from 2003 to 2007 were considerably higher than
previously reported for West Virginia, and statistically significant high-risk clusters for LACV infection were detected
at both the county and census tract levels. The finding of a high CFR and the identification of those areas at
highest risk for infection will be useful for guiding future research and intervention efforts.

Background
La Crosse virus (LACV), a member of the genus Orthobunyavirus, family Bunyaviridae, was first isolated from
the brain of a pediatric patient who died of encephalitis
in 1964 [1]. Since that time LACV has been recognized
as one of the most common causes of pediatric arboviral
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encephalitis in the United States [2,3], with the majority
of cases being reported in children under 15 years of
age [4-8]. There are an average of 79 reported cases per
year nationally [8], however the true incidence of LACV
infections remains unknown, as most are undiagnosed
and/or underreported [8,9]. The virus is transmitted to
humans through the bite of infective mosquitoes, the
primary vector being the eastern tree-hole mosquito,
Aedes triseriatus [10], though two invasive species, the
Asian tiger mosquito, Ae. albopictus, and the Asian
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bush mosquito, Ae. japonicus, have been incriminated as
possible secondary or bridge vectors and both species
are known to feed on humans [11-16]. La Crosse virus
is maintained in a complex cycle involving both horizontal and vertical transmission in mosquitoes, as well
as amplification in sciurid hosts [17-21], and is typically
associated with areas of dense vegetation and/or stands
of hardwood trees where the presence of vector species
overlaps that of the amplification hosts [22-24]. The traditionally reported focus of virus transmission to
humans has been the upper-Midwestern United States
[2,4,5], but more recently LACV has been considered a
major cause of pediatric encephalitic disease in West
Virginia. Notably, West Virginia has led the nation in
the number of annually reported cases since 1994
[8,25,26] (CDC unpublished).
From 1964 to 1986, there were 15 reported cases of
LACV infection in West Virginia, comprising 0.9% of
the nationally reported cases. Then in 1987, a pediatric
referral center located in Charleston, West Virginia
reported several cases of LACV infection. These findings led to active hospital-based surveillance for LACV
infection cases in 15 West Virginian counties, ultimately resulting in the detection of 19 additional cases
[27]. This case series marked a substantial increase in
the number of reported LACV infection cases in the
state and led to increased surveillance and research
efforts. Following this outbreak, from 1987 to 2007,
West Virginia reported 555 cases of La Crosse encephalitis to the Centers for Disease Control and Prevention (CDC), accounting for 31.4% of the total cases
reported in the United States (CDC, unpublished data).
A matched case-control study performed following the
1987 outbreak of LACV in West Virginia found a
slight increase in disease risk for an increased time
spent outdoors, the non-use of insect repellent, the
non-use of air conditioning, a lack of screened windows and the non-use of protective clothing, while the
presence of tree holes (natural water receptacles) near
a residence was found to significantly increase the risk
of virus transmission [28].
We conducted spatial and descriptive analyses of cases
of LACV infection reported in West Virginia from 2003
to 2007 to determine those geographic areas at the highest risk for human infection and to assess both the clinical presentation of cases and the environmental
conditions present at case residences.
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available for 96 cases ranging in age from 0.4 years to
54.0 years (78 confirmed and 18 probable cases). Of
these cases, 81 were 15 years or younger, of which 68
had data available on the location of their primary residence. The location of the primary residence for each
case was determined by a geographic positioning system
(GPS) reading taken at each case residence by the West
Virginia Department of Health and Human Resources.
Personal identifiers of cases were deleted before the data
were released for the study. This research was exempted
from the Institutional Review Board (IRB) review and
certification under section 45 CFR 46.101(b) item 4 of
the University of Tennessee’s categories for exempted
review involving the use of human subjects following a
review by the Departmental Review Committee. The
above item states that a research study may be exempt
from IRB review if the research involves “the collection
of or study of existing data, documents, records, pathological specimens, if these sources are publicly available
or if the information is recorded by the investigator in
such a way that subjects cannot be identified, directly or
through identifiers linked to the subjects.”
Case definition

Confirmed cases of LACV infection are required to
meet both the clinical and laboratory requirements set
by the CDC case definition for neuroinvasive domestic
arboviral diseases [29]. This definition is reprinted
below:
In the absence of a more likely clinical explanation as
documented by a physician, confirmed cases must meet
all of the following criteria:
Clinical criteria

1) Fever, AND 2) Acutely altered mental status, or other
acute signs of central or peripheral neurologic dysfunction, or pleocytosis associated with illness clinically compatible with meningitis,
AND
Laboratory criteria

Methods

3) A four-fold or greater change in virus-specific serum
antibody titer, or isolation of virus from or demonstration of specific viral antigen or genomic sequences in
tissue, blood, CSF, or other body fluid, or virus-specific
immunoglobulin M (IgM) antibodies demonstrated in
CSF by antibody-capture enzyme immunoassay (EIA), or
virus-specific IgM antibodies demonstrated in serum by
antibody-capture EIA and confirmed by demonstration
of virus-specific serum immunoglobulin G (IgG)
antibodies.

Case data

Probable case criteria

Probable and confirmed LACV infection case data were
collected through a passive surveillance system from
2003 to 2007, by the West Virginia Department of
Health and Human Resources. Clinical data were

Cases that met the clinical definition and had stable
(less than or equal to a two-fold change) but elevated
titer of virus-specific serum antibodies, or virus-specific
serum IgM antibodies detected by antibody capture EIA
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but with no available results of a confirmatory test for
virus-specific serum IgG antibodies in the same or a
later specimen, are deemed probable.
Population, geographic, and environmental data

As the majority of LACV infections are pediatric [2,6,7],
it was deemed appropriate to use the population
15 years and younger for the calculation of cumulative
incidence for this study. The decennial 2000 United
States Census was used to calculate the population 15
years and younger for each county and census tract in
West Virginia. Counties are administrative and statistical
subdivisions of a state. Census tracts are subdivisions of
a county typically containing between 2,500 and 8,000
persons and are relatively homogeneous with respect to
population characteristics, economic status and living
conditions. Geographic boundary files were downloaded
from the United States Census, TIGER, Geodatabase
[30], and were used for all cartographic displays. Environmental officers of the West Virginia Department of
Health and Human Resources conducted environmental
assessments at the primary residence of both probable
and confirmed cases’ of LACV infection during the
study period.
Statistical and geographic analyses

Cumulative incidences were calculated at both the
county and the census tract levels, and spatial analyses
were performed on 68 cases 15 years and younger for
which location data were available. Cumulative incidences were calculated for all counties in the study area
(n = 55) and for counties reporting cases (n = 18), as
well as for all census tracts in the study area (n = 466)
and for census tracts reporting cases (n = 50). Cumulative incidence was expressed as the number of cases per
100,000 persons for the study period.
Descriptive analyses and the calculation of cumulative
incidences were performed using STATA 10.0 [31]. The
non-homogeneity of variances and resulting autocorrelation were adjusted for by smoothing the risk using spatial empirical Bayesian (SEB) smoothing [8,32-36]. This
technique was implemented in GeoDa [37] using inverse
distance spatial weights.
Detection of Spatial clusters

The global Moran’s I, implemented in GeoDa [37], was
used to assess the presence of significant spatial autocorrelation of the unsmoothed cumulative incidences.
Detection of spatial clusters of LACV infection were
performed using Kulldorff’s spatial scan statistic [38],
and implemented in SaTScan [39]. A Poisson probability
model was used to scan for geographical areas (counties
and census tracts) with statistically significant high rates
of LACV infections. A maximum spatial cluster size of
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10% of the population 15 years and younger was used.
For statistical inference, 9999 Monte Carlo replications
were performed. The null hypothesis of no clusters was
rejected when the simulated p ≤ 0.05. Cartographic displays were made using ArcView GIS 9.2 [40].

Results
Spatial analyses

The highest cumulative incidences for LACV infection
cases were observed at the census tract level (Table 1).
The cumulative incidence for counties reporting cases
ranged from 7.2 to 166.8 per 100,000 persons (median
32.1), and from 42.4 to 505.9 per 100,000 persons (median 150.0) for those census tracts reporting cases.
The highest unsmoothed risks were observed in the
south-central region of the state at both the county and
census tract levels (Figure 1). Visually, the spatial patterns of SEB smoothed risks at the county and census
tract levels were more evident and followed patterns
similar to those of the unsmoothed risks (Figure 1),
though only some of the census tracts within the highrisk counties had high-risks of infection.
Statistically significant global clustering was detected
at the county and census tracts with global Moran’s I
values of 0.4986 (p = 0.0001) and 0.2935 (p = 0.0001),
respectively. Similarly, statistically significant local
clusters (p < 0.05) of high-risk were detected at both
the county and the census tract levels (Figure 2). At
the county level, two statistically significant high-risk
clusters were identified. The primary statistically significant (p = 0.0001) high-risk cluster consisted of three
counties (Fayette, Raleigh, Nicholas). This cluster had
a cumulative incidence ranging from 100 to 189 cases
per 100,000 persons (median 111) and a relative risk of
9.2 implying that the risk of LACV infection was 9.2
times higher in these three counties than in those
counties in the rest of the state of West Virginia.
A secondary statistically significant (p = 0.0012) highrisk cluster was identified and included Wyoming,
McDowell and Mercer counties. This cluster had a
cumulative incidence ranging from 19 to 111 cases per
100,000 persons (median 40) and a relative risk of 4.3
(Figure 2) implying that the risk of LACV infection in
this cluster was 4.3 times higher than that of those
counties in the rest of the state. At the census tract
level, one statistically significant (p = 0.0001) high-risk
cluster, consisting of 41 census tracts, was identified.
This cluster had a cumulative incidence ranging from
61 to 506 cases per 100,000 persons (median 99.0) and
a relative risk of 6.2, implying that the risk of infection
was 6.2 times higher than those census tracts not contained in the cluster. These census tracts were located
in the following counties: Clay (3 census tracts), Fayette (8 census tracts), Mercer (14 census tracts),

Haddow et al. BMC Infectious Diseases 2011, 11:29
http://www.biomedcentral.com/1471-2334/11/29

Page 4 of 9

Table 1 Comparisons of the Cumulative Incidence of Reported La Crosse Virus Infection Cases in the Population 15
Years and Younger for West Virginia County and Census Tracts, 2003 to 2007
Cumulative incidence per 100,000 persons
Geographic Risk Level

Obs.

Median

Range

Entire Study Area

County

55

0.0

0.0 - 166.8

Reporting Cases

Census tract
County

466
18

0.0
32.1

0.0 - 505.9
7.2 - 166.8

High-Risk Clusters

Census tract

50

150.0

42.4 - 505.9

County

4

83.2

40.2 - 166.8

Census tract

30

156.5

61.7 - 505.9

Obs. = Observations, and refer to the number of counties or census tracts used for each analysis.

Raleigh (13 census tracts), Nicholas (1 census tract),
and Summers (2 census tracts) (Figure 2).
Clinical features

Cases of LACV infection ranged in age from 0.4 to 54.0
years, with a mean age of 10.8 (SD 10.3) years, of which
84.4% occurred in children 15 years and younger (Table 2).

The vast majority of cases presented during July (28.1%),
August (37.5%), and September (16.6%) in the southern
region of the state. The most commonly reported signs
and symptoms in cases were fever (76.0%), vomiting
(75.0%), photophobia (52.1%), and nausea (50.0%) (Table
2). Other reported signs and symptoms included weakness (41.6%), stiff neck and confusion (33.3%), seizures

A

B

Number of Cases Per 100,000 Persons
0.0
0.1 - 8.7
8.7 - 23.9
23.9 - 57.9
57.9 - 102.8
102.8 - 166.8

C

D

Number of Cases Per 100,000 Persons
0.0
0.1 - 42.4
42.4 - 120.8
120.8 - 185.9
185.9 - 277.0
277.0 - 505.9

Figure 1 The unsmoothed and smoothed cumulative incidence of La Crosse virus infections at the county and census tract levels in
children 15 years and younger. The distribution of unsmoothed risk of La Crosse virus infections at the county (A) and the census tract levels
(C) for West Virginia. The distribution of spatial empirical Bayesian smoothed risk for La Crosse virus infections in West Virginia at the county
(B) and the census tract levels (D).
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A

Nicholas
Fayette
Raleigh
Wyoming
McDowell

Mercer

County Clusters
Primary Cluster (RR = 9.24)
Secondary Cluster (RR = 4.3)
County Boundaries

B

Census Tract Cluster
Cluster (RR = 6.21)
Census Tract Boundaries

Figure 2 Spatial clustering of La Crosse virus infection risk at the county and census tract levels in children 15 years and younger.
These maps show the significant high-risk clusters for La Crosse virus infection in West Virginia at the county (A) and at the census tract levels
(B) detected by Kulldorff’s Spatial Scan Statistic. RR = relative risk.
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Table 2 Characteristics of Reported La Crosse Virus
Infection Cases in West Virginia, 2003 to 2007
Variable

Number (%)

Sex
Male
Female

58 (60.4)

Variable

38 (39.6)

Containers*

Age
0.4 - 0.9 yrs
1 - 5 yrs
6 - 10 yrs
11 - 15 yrs

Table 3 The Observed and Reported Environmental
Conditions Present at the Primary Residences of La
Crosse Virus Infection Cases in West Virginia, 2003 to
2007

1 (1.0)

11

33 (40.7)

15

Tarps

32 (41.6)

19

Other containers†

53 (63.1)

12

38 (39.6)

Standing water

41 (49.4)

13

15 (15.6)

Wooded area

81 (92.0)

8

68 (94.4)

24

35 (71.4)

47

27 (28.1)

16 - 20 yrs

6 (6.3)

≥ 21 yrs

9 (9.4)

Evergreen

1 (1.0)

June

8 (8.3)

July

27 (28.1)

August

36 (37.5)

September

16 (16.6)

October

Missing Data

60 (70.6)

Tires

Hardwood

Month of presentation
May

Present (%)

8 (8.3)

Reported Signs and Symptoms
Fever
Vomiting

73 (76.0)
72 (75.0)

Elevated CSF WBC

68 (70.8)

*Containers were all containers including: other containers, tires, and tarps.
These variables were cross-referenced with one another for each case to
determine the presence of at least one variable at each case site.
†
Other containers were those containers not including tires and/or tarps.

in 24 cases (25.0%). Cerebral spinal fluid protein levels
were only available for 27 cases, with a mean level of
64.4, mg/dl (range: 24 to 359 mg/dl, SD: 61.6 mg/dl).
Fever was present in all cases for which temperature
was reported (n = 54), with a mean value of 39.4°C
(range: 38.3°C to 40.6°C, SD: 0.66°C).

Photophobia

50 (52.1)

Nausea

48 (50.0)

Environmental observations

Weakness

40 (41.6)

The most commonly observed environmental variables
at case residences were the presence of a wooded area
(92.0%) and the presence of containers (70.5%), which
provide suitable habitats for mosquito larval development (Table 3). The presence of standing water was
observed at almost half of the case residences (49.4%)
and the majority of case residences (76.7%) were located
within 45.6 m (149.0 ft) of a wooded area (Table 4).

Meningitis

39 (40.6)

Encephalitis

38 (39.6)

Stiff Neck
Confusion

32 (33.3)
32 (33.3)

Seizures

23 (24.0)

Elevated CSF protein

24 (25.0)

Myalgia

11 (11.5)

Rash

7 (7.3)

Arthralgia

7 (7.3)

Coma

4 (4.2)

Male

2 (2.1)

Female

1 (1.0)

Died

(24.0%), and coma (4.2%). Meningitis and encephalitis
were reported in 41.6% and 40.6% of the cases, respectively. A CFR of 3.1% was observed.
Health care providers reported either the presence of
elevated cerebral spinal fluid (CSF) white blood cell
(WBC) counts and/or the determined the counts. Elevated CSF WBC counts were reported in 73 cases
(76.0%), of which 68 cases had a mean CSF WBC count
of 160.9 per mm3 (range: 10 to 670 per mm3, SD: 153.8
per mm3). Health care providers also either reported the
presence of elevated CSF protein levels and/or the CSF
protein levels. Elevated CSF protein levels were reported

Discussion
Traditionally the highest number of reported LACV
infection cases came from the upper-Midwestern states,
but during the last 20 years the geographic area with
the highest number of reported cases shifted to the
Appalachian region of the United States [8]. Within this
region, West Virginia now leads the nation in the number of reported cases annually [8]. To investigate the
epidemiology of LACV infections in West Virginia, we
performed spatial and descriptive analyses of LACV
infection cases reported to the West Virginia Department of Health and Human Resources from 2003 to
2007.
The results of this study found that the highest cumulative incidences of LACV infection were located in the
south-central region of the state, similar to the results of
previous studies [27,28]. Furthermore, both the
unsmoothed and SEB smoothed cumulative incidences
were the highest in this region at both the county and
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Table 4 The Numbers of Observed and Reported
Potential Larval Habitats Present at the Primary
Residences of La Crosse Virus Infection Cases in West
Virginia, 2003 to 2007
Variable

Number (%)

No. of tires

20

0

49 (64.5)

1-9

21 (27.6)

≥ 10

7 (9.2)

No. of tarps

31

0

46 (70.8)

1 - 10

21 (32.3)

No. of other types of
Containers*

23

0
1-5

19 (26.0)
29 (39.7)

6 - 15

10 (13.7)

≥ 16

3 (4.1)

Distance (meters) from
residence to wooded
area

23

0 - 14.9 (0 - 49 ft)

35 (47.9)

15 - 45.6 (50 -149 ft)

21 (28.8)

≥ 45.7 (≥ 150 ft)

Missing Data

6 (8.2)

*Other types of containers were those containers not including tires and/or
tarps.

census tract levels. To determine those areas at the
highest risk for disease, we performed spatial analyses at
two different spatial levels (county and census tract).
The census tract level was used in this study over a
smaller geographic level (i.e., census block) because this
is typically the smallest spatial level that is acceptable
for the public reporting of diseases under the Health
Insurance Portability and Accountability Act (HIPAA)
and due to the availability of census data variables during the study period. The high cumulative incidences
observed in this study were similar to those high cumulative incidences reported in eastern Tennessee [36], the
location of another area of high-risk LACV infection
case clustering in the Appalachian region [8,36]. Significant high-risk clustering was observed at both the
county and census tract levels in the south-central
region of West Virginia. Two statistically significant
clusters of high LACV infection risk (comprising six
counties) were detected at the county level with a relative risk roughly four to nine fold higher than those
counties located outside of the high-risk clusters, and
one statistically significant cluster (comprising 41 census
tracts within six counties) was observed at the census
tract level with a relative risk about six times higher
compared to those census tracts located outside of the
high-risk cluster. These areas of high-risk should form
the focus of education and intervention efforts in the

future. Additionally, the results of this study reaffirm
that the census tract level is the preferred geographic
level for reporting cases and conducting analyses of
focal diseases [36,41].
In agreement with previous work [7,8], our study
found that the majority of reported LACV infections
occur in male children 15 years and younger during the
summer months, and that cases display fever, headache,
vomiting, and mental status changes. La Crosse virus
infection has traditionally proven difficult to distinguish
from herpes simplex meningoencephalitis [7,42]. Our
study demonstrates that elevated CSF WBCs remain a
hallmark of LACV infection, however it should be noted
that patients frequently demonstrate a predominance of
polymorphonuclear leukocytes on their peripheral blood
smears and in their CSF, which is suggestive of a bacterial infection and may result in a delayed diagnosis of
LACV infection [7]. A troubling discovery in this study
was the continued high CFR (3.1%) in West Virginia
[28], compared to a lower CFR (1.5%) reported during
the same time period for the rest of the United States
[8]. The reason for this higher CFR in West Virginia is
unclear, but may indicate the possibility of a more virulent strain(s) of the virus circulating in this region
[43,44], reporting bias, clinical management, and/or
chance variation. The reasons underlying the increased
CFR warrant further investigation.
The reason for the increase in the number of reported
cases of LACV infection in the Appalachia region and in
West Virginia, in the past 20 years remains unknown. One
possibility is a change in the geographic distribution of vector species, and recent work has indicated a possible geographic shift in vector abundance between Ae. triseriatus,
Ae. albopictus, and Ae. japonicus populations in West Virginia [45-47]. Of interest, the number of reported cases of
LACV infection in West Virginia has decreased in recent
years (2005 to 2009) when compared to data from the previous decade (CDC unpublished). Prior to the establishment of Ae. albopictus and Ae. japonicus in West Virginia,
LACV had been isolated from Ae. triseriatus mosquitoes
collected in 1996 at former sites of confirmed LACV infection cases in West Virginia [26]. A recent survey of abandoned tires to determine the presence of mosquito larvae
in western, central and eastern West Virginia found that
Ae. japonicus was the most frequently collected larval mosquito species throughout the state in this habitat type.
Furthermore, their survey revealed that Ae. albopictus was
collected at significantly lower numbers than Ae. triseriatus
at both peridomestic and non-peridomestic tire sites in the
central region of the state [45], where the results of this
study indicate the highest disease risk. However, a study in
eastern Tennessee collecting adult host-seeking mosquitoes
using CO2 baited CDC traps from 2004 to 2006 found that
Ae. albopictus was three times more likely to be collected
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than Ae. triseriatus at the residences of previously confirmed LACV cases, in addition to residences without a
prior history of reported LACV cases [14]. Similar results
were observed at active LACV case residences using
human landing collections in 2004 [14].
The observation that a large number of case residences
in this study were in close proximity to wooded areas and
had the presence of containers are in agreement with
those findings of a case-control study previously performed in this region which found them to be risk factors
for LACV infection in West Virginia [28]. Such characteristics provide a habitat for vector species and amplification
hosts [20-24]. Thus, as observed elsewhere, the closure of
tree-holes and the elimination of water-holding containers
would likely reduce the overall burden of infective mosquitoes and decrease the risk of LACV transmission [48].
Importantly, although LACV has not been isolated from
mosquitoes in West Virginia since 1996, the lack of isolates are likely the result of extremely limited testing of
mosquito pools for LACV rather than a true lack of virus
presence in mosquito populations. Ultimately, the status
of Ae. triseriatus, Ae. albopictus, and Ae. japonicus concerning the transmission and maintenance of LACV in
West Virginia remains unknown, and research is urgently
needed to fill this gap in our understanding of the epidemiology of LACV.

Limitations
Due to the methodology and data employed in our
study there are some limitations. Passive surveillance
systems are prone to under-reporting/detection of disease, though we feel that the majority of cases suffering
from severe illness were diagnosed and reported to state
health officials. Clinical data were collected from multiple health care providers by local health department
personnel for the purpose of case ascertainment. Due to
limited resources, verification of complete and accurate
reporting of laboratory and clinical features was not
possible. As data regarding the clinical features of cases
of LACV infection were extracted from patient charts
and/or recalled by healthcare professionals post-presentation of disease, the actual frequency of reported signs
and symptoms could be higher than those reported in
this study. Missing information for environmental data
resulted when visits to the cases’ residences were not
possible. The environmental information presented in
this paper is purely for descriptive purposes and is not
intended to infer an association with LACV infections.
Conclusions
During the study period, West Virginia reported the
highest cumulative incidence of LACV infection cases in
the United States, marking a shift from the traditional
geographic focus of reported LACV infection cases from
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the upper-Midwestern states to the Appalachian region
[8]. The reason for this shift is unclear, but could be due
to a variety of factors including increases and/or
decreases in diagnosis, reporting, education, and prevention. Additionally, changes in virus strain virulence, the
distribution of vector species, land use patterns, forest
succession and/or increased human encroachment into
enzootic foci could also be contributing factors. Future
surveillance efforts should include both the screening of
vector species for virus, as well as determining the seroprevalence to LACV in amplification hosts. In addition,
LACV isolations are needed so West Virginian virus
strains can be compared with virus strains from other
regions to determine if differences exist in virulence and
vector competence. Although the reporting of the clinical
presentation of cases of LACV infection through a passive surveillance system is not without limitations, such
reporting will allow for the continued monitoring of
infection patterns. The findings of this study demonstrate
that south-central West Virginia remains a focus of
LACV transmission and highlights the utility of using the
combination of cumulative incidence, relative risk, and
spatial statistics to determine those geographic areas at
highest risk for infection. The majority of reported LACV
infection cases during the study period had the presence
of wooded areas and containers near their primary residence corroborating the results of a previous case-control
study. Finally, the results of this study will be useful for
guiding disease control strategies and will allow public
health officials to target specific areas for interventions.
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